Suppr超能文献

在缓冲液中由血液因子 XII 自动激活产生的酶:来自血液学分界面生物材料研究组的贡献。

Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.

机构信息

Department of Materials Science and Engineering, The Pennsylvania State University, University Park, PA 16802, USA.

Department of Bioengineering, The Pennsylvania State University, University Park, PA 16802, USA; Department of Surgery, Pennsylvania State University College of Medicine, Biomedical Engineering Institute, Hershey, PA 17033, USA.

出版信息

Biomaterials. 2015 Jan;37:1-12. doi: 10.1016/j.biomaterials.2014.09.015. Epub 2014 Oct 31.

Abstract

High-resolution electrophoresis of FXII-derived proteins produced by contact activation of FXII in buffer solutions (i.e. in absence of plasma proteins) with hydrophilic and silanized-glass activators spanning the observable range of water wettability (hydrophilic to hydrophobic), shows no evidence of proteolytic cleavage of FXII into αFXIIa or βFXIIa. The autoactivation mixture contains only a single-chain protein with a molecular weight of ∼80 kDa, confirming Oscar Ratnoff's previous finding of a single-chain activated form of FXII that he called 'HFea'. Functional assays have shown that these autoactivation products exhibit procoagulant potential (protease activity inducing clotting of blood) or amidolytic potential (cleaves amino bonds in s-2302 chromogen but do not cause coagulation of plasma) or both amidolytic potential and procoagulant potential. Some of these proteins also have the remarkable potential to 'suppress autoactivation' (i.e. suppress creation of enzymes with procoagulant potential). It is thus hypothesized that autoactivation of FXII in the absence of plasma proteins generates not just a single type of activated conformer, as suggested by previous researchers, but rather an ensemble of conformer products with collective activity that varies with activator surface energy used in contact activation of FXII. Furthermore, reaction of αFXIIa with FXII in buffer solution does not produce additional αFXIIa by the putative autoamplification reaction FXIIa + FXII → 2FXIIa as has been proposed in past literature to account for the discrepancy between chromogenic and plasma-coagulation assays for αFXIIa in buffer solution. Instead, net procoagulant activity measured directly by plasma-coagulation assays, decreases systematically with increasing FXII solution concentration. Under the same reaction conditions, chromogenic assay reveals that net amidolytic activity increases with increasing FXII solution concentration. Thus, although autoamplification does not occur it appears that there is some form of "FXII self reaction" that influences products of αFXIIa reaction with FXII. Electrophoretic measurements indicate that no proteolytic cleavage takes in this reaction leading us to conclude that change in activity is most likely due to change(s) in FXII conformation (with related change in enzyme activity).

摘要

在缓冲液(即不存在血浆蛋白)中,通过接触激活 FXII 产生 FXII 衍生蛋白的高分辨率电泳,使用跨越可观察的润湿性范围(亲水到疏水)的亲水和硅烷化玻璃激活剂,没有证据表明 FXII 被蛋白水解切割成 αFXIIa 或 βFXIIa。自激活混合物仅包含一种单链蛋白质,分子量约为 80 kDa,证实了 Oscar Ratnoff 之前发现的 FXII 的单链激活形式,他称之为'HFea'。功能测定表明,这些自激活产物表现出促凝潜力(诱导血液凝固的蛋白酶活性)或酰胺酶潜力(切割 s-2302 显色底物中的氨基键,但不会引起血浆凝固)或两者兼有。其中一些蛋白质还具有显著的“抑制自激活”的潜力(即抑制具有促凝潜力的酶的产生)。因此,假设 FXII 在不存在血浆蛋白的情况下的自激活不仅产生以前研究人员所建议的单一类型的激活构象体,而是产生具有集体活性的构象体产物的集合,其活性随用于 FXII 接触激活的激活剂表面能而变化。此外,在缓冲液中,αFXIIa 与 FXII 的反应不会像过去文献中提出的那样通过假定的自扩增反应 FXIIa + FXII → 2FXIIa 产生额外的 αFXIIa,以解释缓冲液中 αFXIIa 的显色和血浆凝固测定之间的差异。相反,直接通过血浆凝固测定测量的净促凝活性随着 FXII 溶液浓度的增加而系统地降低。在相同的反应条件下,显色测定表明净酰胺酶活性随着 FXII 溶液浓度的增加而增加。因此,尽管没有自扩增发生,但似乎存在某种形式的“FXII 自我反应”,影响 αFXIIa 与 FXII 反应的产物。电泳测量表明,该反应中没有蛋白水解切割,这使我们得出结论,活性的变化很可能是由于 FXII 构象的变化(与酶活性的相关变化)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验